Harvard Bioscience: Q4 Earnings Insights

Harvard Bioscience HBIO reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Harvard Bioscience missed estimated earnings by 20.0%, reporting an EPS of $0.08 versus an estimate of $0.1.

Revenue was up $2.07 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 2.05% increase in the share price the next day.

Here's a look at Harvard Bioscience's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.06	0.06	0.03	0.06
EPS Actual	0.06	0.06	0.05	0.08
Revenue Estimate	27.91M	27.67M	25.73M	27.13M
Revenue Actual	29.66M	29.20M	26.99M	30.98M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar